Mission Bend, TX, United States
Mission Bend, TX, United States

Time filter

Source Type

Nominated nurses from across each state as well as coworkers, families and friends attended events SAN ANTONIO, TX--(Marketwired - November 30, 2016) - Mission Pharmacal Company (Mission) served as Platinum Sponsor for two recent March of Dimes (MOD) Annual Nurse of the Year (NOTY) Awards events. The first occurred on Wednesday, November 16, when MOD North Central New Jersey conducted its 11th Annual NOTY Awards celebration at Pines Manor in Edison, New Jersey. Then, on Saturday, November 19, the MOD Georgia NOTY event took place at the Grand Hyatt Hotel in Atlanta. In addition, two Mission product lines -- Dr. Smith's® consumer baby line of products and the CitraNatal® Family of prescription prenatal vitamins -- also sponsored two specific NOTY awards categories, Pediatrics and Women's Health. In New Jersey, the nurse winners for the two Mission sponsored categories were: The three nurse winners for the Mission sponsored categories in Georgia were: "We congratulate all of the wonderful Nurse of the Year finalists and winners in New Jersey, Georgia, and throughout the country," notes Leslie Painter, Mission Pharmacal District Sales Manager, Women's Health & National Sales Team Captain, March of Dimes/March for Babies. "Mission is truly proud of our involvement with MOD and there are many parallels between our two organizations. As Mission enters our seventh decade, we continue to pioneer innovative products that meet the needs of both women and babies, just as MOD continues its support of research, education, vaccines, and breakthroughs that help improve the health of babies." The New Jersey and Georgia events are two of more than 15 NOTY Awards Celebrations held across the United States each year. These celebrations help raise awareness of how important the nursing community is in caring for families, while also demonstrating the deep appreciation MOD, event sponsors, and all in attendance have for these special nurses. Beyond the well-deserved recognition of the many outstanding nurses, the NOTY Awards celebrations also help raise much needed funds for MOD. November was MOD "Prematurity Awareness Month" and November 17 was "World Prematurity Day." At the start of the month, MOD issued its annual Premature Birth Report Card, providing a look at how well the United States, each state, and counties in each state across the country are doing to reduce the serious problem of premature birth in the U.S. For the first time in eight years, the rate of premature birth has gotten worse, driven by higher rates among specific racial and ethnic groups as well as geographic areas. The U.S. received a "C" grade on the report card, falling short of the organization's goal of reducing the preterm birth rate. "From a personal level, I am the mother of two beautiful girls who were born prematurely," notes Natalie Sirjuesingh, Senior Vice President, Corporate Marketing at Mission Pharmacal. "When our girls were born we relied heavily on doctors and nurses in the neonatal intensive care unit (NICU) who thankfully had the support of March of Dimes. At the time, we weren't fully aware of all that MOD does, yet through the years have really learned what they are all about and how much they give back to support doctors, nurses, and hospitals. It makes me proud that the company I work for has supported MOD both financially and through the volunteer efforts of our leadership and employees." Mission, a privately held pharmaceutical company based in San Antonio, has been a national supporter of the March of Dimes Foundation since 2010 and has contributed more than $1.5 million dollars to the organization in corporate sponsorship and fundraising efforts. About the March of Dimes The March of Dimes is the leading nonprofit organization for pregnancy and baby health. For more than 75 years, moms and babies have benefited from March of Dimes research, education, vaccines, and breakthroughs. For the latest resources and health information, visit their websites marchofdimes.org and nacersano.marchofdimes.org. You can also find them on Facebook or follow them on Twitter. About Mission Pharmacal Company Mission Pharmacal Company is a privately held pharmaceutical company based in San Antonio, Texas. For seven decades, the company has been improving the lives of people through every stage of life by identifying unmet healthcare needs and delivering innovative, high-quality prescription, over-the-counter, and dietary supplement products to meet these needs using only the purest ingredients and FDA-approved methods of manufacturing. Mission is recognized as a pioneer and leader in the therapeutic areas of women's health and urology and also offers leading products through its pediatric, dermatology, primary care, and long-term care service lines. Using an innovative business model, Mission has created wholly-owned subsidiaries, BioComp Pharma, Inc., a generic drug marketer; Alamo Pharma Services, Inc., a specialized contract sales organization; ProSolus, Inc., a transdermal drug developer and manufacturer; and BexR Logistics LLC, a logistics and fulfillment arm, to diversify its offerings and build forward-thinking partnerships with other pharmaceutical and biotech companies. Mission Pharmacal is a proud national supporter of the March of Dimes Foundation®, whose mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality. To learn more, please visit missionpharmacal.com.


Now in its eighth year, partnership offers clear demonstration of Mission's commitment to families and stronger, healthier babies SAN ANTONIO, TX--(Marketwired - February 09, 2017) - Mission Pharmacal Company ("Mission") celebrated the kick off of its 2017 fundraising campaign in support of the March of Dimes Foundation®, and it's signature fundraiser March for Babies. The March of Dimes is committed to a world in which every baby gets a fighting chance. The company has been a national supporter of the March of Dimes since 2010 and during that time has contributed more than $2.1 million dollars to the organization through corporate sponsorship and fundraising efforts. March for Babies, one of the nation's favorite walking events, funds programs and research to address the health issues that threaten pregnant women and babies. This internal, employee-driven campaign is one element of the company's overall partnership with the March of Dimes. "There are many reasons Mission Pharmacal is continuing our partnership with MOD," states Mission Senior Vice President of Corporate Marketing Natalie Sirjuesingh. "First and foremost, we believe in March of Dimes' work to help every mother and baby. We believe that raising funds that help achieve their goals is simply the right thing to do. This is the eighth year of the partnership and I am proud of the commitment we've shown as a company and how our employees continue to rally to embrace and support the cause. It truly is an 'all hands on deck' effort for us -- from Mission owners and leadership team members, to the workers in our manufacturing plants, to the employees throughout all of the Mission Family of Companies." On a national level, any individual who raises $1,000 or more through March for Babies will be named a Champion for Babies. Mission employs many who have earned this notable distinction, and as a corporation Mission was the second highest ranked company in terms of 2016 March of Dimes fundraising throughout the San Antonio region. While most March for Babies fundraisers are set for April 29 and 30, events are held in nearly 500 communities nationwide. While Mission employees will participate in several cities, the company will have a more formalized presence at the San Antonio march on Saturday, May 13. That event will also serve as the culmination for the company's March for Babies fundraising campaign. Mission's involvement with the March of Dimes extends well beyond March for Babies support, however. Last year the company, makers of the CitraNatal® Family of prescription prenatal vitamins and Dr. Smith's® consumer baby line of products, served as Platinum Sponsor for the New Jersey and Georgia MOD Annual Nurse of the Year (NOTY) Awards events and sponsored two specific NOTY awards categories, Women's Health and Pediatrics. More than 380,000, or 1 in 10 babies, are born too soon in the United States each year. Preterm birth (birth before 37 weeks of pregnancy) is the number one killer of babies, and babies who survive early birth often face an increased risk of a lifetime of health challenges, such as breathing problems, cerebral palsy, intellectual disabilities, and more. In late 2016, the March of Dimes issued its annual Premature Birth Report Card, providing a look at how well the United States, each state, and counties in each state across the country are doing to reduce the serious problem of premature birth. For the first time in eight years, the rate of premature birth has gotten worse, driven by higher rates among specific racial and ethnic groups as well as geographic areas. The U.S. received a "C" grade on the report card, falling short of the organization's goal of reducing the preterm birth rate. "There are many parallels between our two organizations," says Sirjuesingh. "For more than 70 years Mission has pioneered innovative products, many of which were specifically formulated to meet the needs of women and babies. During almost that exact same timeframe, March of Dimes has continually supported research, education, vaccines, and breakthroughs that have helped improve the health of babies. It seems like a natural fit to have our two organizations work together for a common good." About the March of Dimes The March of Dimes is the leading nonprofit organization for pregnancy and baby health. For more than 75 years, moms and babies have benefited from March of Dimes research, education, vaccines, and breakthroughs. For the latest resources and health information, visit marchofdimes.org and nacersano.marchofdimes.org. To participate in our annual signature fundraising event, visit marchforbabies.org. If you have been affected by prematurity or birth defects, visit the shareourstory.org community to find comfort and support. For detailed national, state and local perinatal statistics, visit peristats.org. You can also find us on Facebook, Instagram, and Twitter. About Mission Pharmacal Company Mission Pharmacal Company is a privately held pharmaceutical company based in San Antonio, Texas. For more than seven decades, the company has been improving the lives of people through every stage of life by identifying unmet healthcare needs and delivering innovative, high-quality prescription, over-the-counter, and dietary supplement products to meet these needs using only the purest ingredients and FDA-approved methods of manufacturing. Mission is recognized as a pioneer and leader in the therapeutic areas of women's health and urology and also offers leading products through its pediatric, dermatology, primary care, and long-term care service lines. Using an innovative business model, Mission has created wholly-owned subsidiaries, BioComp Pharma, Inc., a generic drug marketer; Alamo Pharma Services, Inc., a specialized contract sales organization; ProSolus, Inc., a transdermal drug developer and manufacturer; Espada Dermatology, Inc., a consumer dermatology division; as well as BexR Logistix, LLC and their subsidiary company, EPIC Fulfillment, Inc., the logistics and fulfillment arms of Mission, to diversify its offerings and build forward-thinking partnerships with other pharmaceutical and biotech companies. Mission is proud to support the March of Dimes Foundation®, the leading nonprofit organization for pregnancy and baby health. To learn more, please visit missionpharmacal.com.


Patent
Mission Pharmacal Company | Date: 2015-02-11

A sprayable zinc oxide composition is provided. The sprayable zinc oxide composition can be used in the treatment of various skin conditions. The sprayable zinc oxide composition includes zinc oxide particles and a fluoro-olefin propellant. The present inventors have found that by selecting a propellant having a certain specific gravity, vapor pressure, and molecular weight, and by controlling the viscosity of the various components of the composition, the resulting zinc oxide composition resists settling such that a substantially homogeneous distribution of zinc oxide particles is maintained and can be evenly sprayed onto a surface without running once applied.


Patent
Mission Pharmacal Company | Date: 2015-02-11

A sprayable emulsion is provided. The emulsion can be used in the treatment of various skin conditions. The emulsion includes a hydrofluoro-based propellant, an emulsification system, an oil phase, a water phase, and active agent particles. Further, the emulsification system includes at least one nonionic emulsifier. The emulsion has a viscosity ranging from about 500 centipoise to about 10,000 centipoise and a hydrophilic to lipophilic balance (HLB) value of from about 2 to about 12. The present inventors have found that by selectively controlling the nature of the emulsification system and the viscosity of the emulsion, the active agent particles resist settling such that a substantially homogeneous distribution of the active agent particles is maintained and can be evenly sprayed onto a surface without running once applied.


Patent
Mission Pharmacal Company | Date: 2015-02-11

A spray delivery system including a sprayable active agent composition housed within a container is provided that can be used in the treatment of various skin conditions. The composition includes a hydrofluoro-based propellant, a carrier fluid, and active agent particles, and has a viscosity ranging from about 500 centipoise to about 10,000 centipoise. The container includes a dip tube; a valve assembly that includes a valve body, a stem comprising a stem orifice, and a vapor tap; and an actuator. The dip tube is coupled to the actuator by the valve assembly, and the actuator is depressed to dispense the emulsion. By selectively controlling the components and viscosity of the composition and the dimensions of the container components, the active agent particles resist settling so a substantially homogeneous distribution of the particles is maintained. Thus, the composition can be evenly dispensed from the container as a fine mist without clogging.


Patent
The University Of Texas and Mission Pharmacal Co. | Date: 2011-06-07

Small molecules and their derivatives are described for the treatment and/or prevention of intestinal fluid loss. Also disclosed are methods of using said molecules and their derivatives to treat and/or prevent conditions associated with increased levels of 3,5-adenosine monophosphate. Specific compositions of the invention are also novel.


Patent
Mission Pharmacal Company | Date: 2016-06-06

A sprayable emulsion is provided. The emulsion can be used in the treatment of various skin conditions. The emulsion includes a hydrofluoro-based propellant, an emulsification system, an oil phase, a water phase, and active agent particles. Further, the emulsification system includes at least one nonionic emulsifier. The emulsion has a viscosity ranging from about 500 centipoise to about 10,000 centipoise and a hydrophilic to lipophilic balance (HLB) value of from about 2 to about 12. The present inventors have found that by selectively controlling the nature of the emulsification system and the viscosity of the emulsion, the active agent particles resist settling such that a substantially homogeneous distribution of the active agent particles is maintained and can be evenly sprayed onto a surface without running once applied.


Patent
Mission Pharmacal Co. and The Board Of Regents Of The University Of Texas System | Date: 2010-05-20

A composition comprising a powder mixture of potassium citrate and calcium citrate as mixtures of pure chemical salts and methods of making and using the composition are disclosed. The composition is useful for the treatment and prevention of kidney stones and osteoporosis and better delivers potassium and calcium than commonly used potassium and calcium supplements.


Patent
Laval University and Mission Pharmacal Company | Date: 2014-06-25

The present disclosure provides novel formulations suitable for the intravaginal delivery of tinidazole, as well as methods of using the same.


Patent
Mission Pharmacal Company | Date: 2010-01-04

Compounds are provided herein which are coordination complexes of the formula, A_(x)B_(y)Cit_(2)F_(z).mH_(2)O, wherein A is a cation selected from certain IA or IIA metal ions in the Periodic Table; B is a cation selected from certain IIA metal ions and certain divalent d-block transition metal ions; A and B are different; Cit is tribasic citric acid anion; the stoichiometric ratio of x to y is equal or higher than 1.0 but lower than 8.0; m is 0-12; and z is selected such that electroneutrality is preserved. Compounds provided herein are useful to treat dietary deficiencies, osteoporosis, osteopenia, bone loss, and risk of bone loss, as well as other medical conditions involving the need for administration of the various ions. In addition, the compounds can be used as fluoride sources for dental use and to fluoridate water systems.

Loading Mission Pharmacal Company collaborators
Loading Mission Pharmacal Company collaborators